Jean Nordstrom of Sixera Pharma AB joined us for World Orphan Drug Congress USA 2015 to present about ‘ Restoring Skin Barrier Function: New Treatment for Netherton Syndrome’ .
Download the presentation now to learn about:
- Unmet medical need and market
- In Vivo proof of principle
- Project status and next steps
…and much more!
Get your copy here!
To find out more about how Sixera Pharma AB’s new treatment for Netherton Syndrome , join us at World Orphan Drug Congress USA 2016 April 20-22 in Washington, DC.